Near-patient SARS-CoV-2 molecular platforms: new-old tools for new-old problems.

Moore, Luke S P

Moore, Luke S P.

Moore LSP; Chelsea and Westminster NHS Foundation Trust, London SW10 9NH, UK; North West London Pathology, Imperial College Healthcare NHS Trust, London, UK; National Institute for Health Research Health Protection Research Unit in Healthcare-Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK. Electronic address: luke.moore@nhs.net.

Lancet Respir Med ; 8(12): 1161-1163, 2020 12.

Article in English | MEDLINE | ID: covidwho-1023781

Subject(s)

COVID-19; SARS-CoV-2; Hospitals; Humans; Pandemics; Point-of-Care Testing; Prospective Studies

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Limits: Humans Language: English Journal: Lancet Respir Med Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google